These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28631752)

  • 1. Dyslipidaemia: Statin-associated muscle symptoms - really all in the mind?
    Stoekenbroek RM; Kastelein JJP
    Nat Rev Cardiol; 2017 Aug; 14(8):445-446. PubMed ID: 28631752
    [No Abstract]   [Full Text] [Related]  

  • 2. MY APPROACH to Managing Statin-Associated Muscle Symptoms.
    Thompson PD
    Trends Cardiovasc Med; 2017 Feb; 27(2):160-161. PubMed ID: 28107840
    [No Abstract]   [Full Text] [Related]  

  • 3. New insights into managing symptoms during statin therapy.
    Robinson JG
    Prog Cardiovasc Dis; 2019; 62(5):390-394. PubMed ID: 31669768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on SAMS: Statin-associated muscle symptoms.
    Stock JK
    Atherosclerosis; 2018 Feb; 269():260-261. PubMed ID: 29361270
    [No Abstract]   [Full Text] [Related]  

  • 5. Statin Intolerance From a Clinician's Perspective.
    Whayne TF
    Angiology; 2016 Mar; 67(3):205-7. PubMed ID: 26019266
    [No Abstract]   [Full Text] [Related]  

  • 6. Managing statin myopathy.
    Venero CV; Thompson PD
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):121-36. PubMed ID: 19217515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin myopathy: the iceberg or its tip?
    Campbell WW
    Muscle Nerve; 2006 Oct; 34(4):387-90. PubMed ID: 16810688
    [No Abstract]   [Full Text] [Related]  

  • 8. Autoimmune myopathy due to statin treatment in an elderly woman.
    Nicolas B; Berthier S; Sordet-Guépet H; Aubriot-Lorton MH; Manckoundia P
    J Am Geriatr Soc; 2014 May; 62(5):991-2. PubMed ID: 24828936
    [No Abstract]   [Full Text] [Related]  

  • 9. Step-by-step diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP).
    Penson PE; Bruckert E; Marais D; Reiner Ž; Pirro M; Sahebkar A; Bajraktari G; Mirrakhimov E; Rizzo M; Mikhailidis DP; Sachinidis A; Gaita D; Latkovskis G; Mazidi M; Toth PP; Pella D; Alnouri F; Postadzhiyan A; Yeh HI; Mancini GBJ; von Haehling S; Banach M;
    J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1596-1622. PubMed ID: 35969116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel.
    Banach M; Rizzo M; Toth PP; Farnier M; Davidson MH; Al-Rasadi K; Aronow WS; Athyros V; Djuric DM; Ezhov MV; Greenfield RS; Hovingh GK; Kostner K; Serban C; Lighezan D; Fras Z; Moriarty PM; Muntner P; Goudev A; Ceska R; Nicholls SJ; Broncel M; Nikolic D; Pella D; Puri R; Rysz J; Wong ND; Bajnok L; Jones SR; Ray KK; Mikhailidis DP
    Expert Opin Drug Saf; 2015 Jun; 14(6):935-55. PubMed ID: 25907232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of statin myopathy after statin withdrawal.
    Armour R; Zhou L
    J Clin Neuromuscul Dis; 2013 Mar; 14(3):103-9. PubMed ID: 23492461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can alternate-day Statin regimen minimize its adverse effects on muscle and tendon? A systematic review.
    Muhammad ZA; Ahmad T; Baloch N
    J Pak Med Assoc; 2019 Jul; 69(7):1006-1013. PubMed ID: 31308572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing statin adverse effects in the clinic: the 5 Ms.
    Katz DH; Intwala SS; Stone NJ
    J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):533-42. PubMed ID: 24770611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin use and its association with musculoskeletal symptoms--a cross-sectional study in primary care settings.
    Mosshammer D; Lorenz G; Meznaric S; Schwarz J; Muche R; Mörike K
    Fam Pract; 2009 Apr; 26(2):88-95. PubMed ID: 19233960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin-associated muscle symptoms EAS Consensus Panel paper focuses on this neglected patient group.
    Stock J
    Atherosclerosis; 2015 Sep; 242(1):346-50. PubMed ID: 26253793
    [No Abstract]   [Full Text] [Related]  

  • 16. Statin-induced myopathy in a patient with previous poliomyelitis.
    Martikainen MH; Gardberg M; Kohonen Ia; Lähdesmäki J
    Am J Phys Med Rehabil; 2013 Nov; 92(11):1031-4. PubMed ID: 23370588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Muscle pain and statin, pharmacological or nocebo effect?].
    Khouri C; Lepelley M; Mallaret M; Roustit M; Cracowski JL
    Therapie; 2018 Sep; 73(4):359-361. PubMed ID: 29366501
    [No Abstract]   [Full Text] [Related]  

  • 18. Immune Mediated Myopathy following Long-Term Statin Therapy.
    Watad A; Soriano A; Vaknine H; Shoenfeld Y; Amital H
    Isr Med Assoc J; 2015 Feb; 17(2):128-9. PubMed ID: 26223095
    [No Abstract]   [Full Text] [Related]  

  • 19. [Intense physical exercise, muscle involvement and statin use].
    Toussirot E; Michel F; Meneveau N
    Presse Med; 2014 Jun; 43(6 Pt 1):726-7. PubMed ID: 24630267
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk identification and possible countermeasures for muscle adverse effects during statin therapy.
    Magni P; Macchi C; Morlotti B; Sirtori CR; Ruscica M
    Eur J Intern Med; 2015 Mar; 26(2):82-8. PubMed ID: 25640999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.